State of play in advanced prostate cancer: a multi-disciplinary expert discussion

Learning objective:         

After attending this symposium, participants should be able to:

• Analyse and apply the most recent advances in mHSPC to daily practical management
• Discuss the consequences of treatment choices in mHSPC on sequencing in mCRPC

Scientific committee:

• Elena Castro (Spain)
• Axel Merseburger (Germany)

Faculty:

• Stefano Fanti (Italy)
• Thomas Zilli (Switzerland)